abstract |
The present invention relates to novel 2-amino-3,4-dihydroquinazoline derivatives, pharmaceutical compositions containing them and their use in the treatment of Alzheimer's disease (AD) and related disorders. The compounds of the present invention are inhibitors of P-secretase, also known as n-site cleavage enzyme and BACE. |